Testicular Cancer and Platinum: A Double-Edged Sword

Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis

(2012) Sonia Seng et al.   JOURNAL OF CLINICAL ONCOLOGY

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

(2011) Russell A. Moore et al.   JOURNAL OF CLINICAL ONCOLOGY

Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report

(2009) Alper Azak et al.   ANTI-CANCER DRUGS

Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report

(2009) Klaus-Peter Dieckmann et al.   BMC CANCER

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

(2009) Giancarlo Agnelli et al.   LANCET ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD

Efficacy of Low- molecular- weight- heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials

(2008) Martha L. Louzada et al.   THROMBOSIS RESEARCH